A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
ALX Oncology Inc.
NiKang Therapeutics, Inc.
Eli Lilly and Company
Pliant Therapeutics, Inc.
Samsung Medical Center
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Eli Lilly and Company
Kivu Bioscience Inc.
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Plexium, Inc.
Memorial Sloan Kettering Cancer Center
NRG Oncology
Alterome Therapeutics, Inc.
IDEAYA Biosciences
Aulos Bioscience, Inc.
Assistance Publique - Hôpitaux de Paris
Memorial Sloan Kettering Cancer Center
Aptamer Sciences, Inc.
National Institutes of Health Clinical Center (CC)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Institut Paoli-Calmettes
Orano Med LLC
Conjupro Biotherapeutics, Inc.
Regeneron Pharmaceuticals
Frontier Medicines Corporation
Stanford University
PMV Pharmaceuticals, Inc
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
University Hospital Heidelberg
Ankyra Therapeutics, Inc
N-Power Medicine
M.D. Anderson Cancer Center
ViroMissile, Inc.
Avenzo Therapeutics, Inc.
Tizona Therapeutics, Inc
Tasca Therapeutics
Essen Biotech
Essen Biotech
InSilico Medicine Hong Kong Limited
Clasp Therapeutics, Inc.
Revolution Medicines, Inc.
MacroGenics